What are the main differences between DOH and DHA?

DOH (Abu Dhabi) is centralized and evidence-driven, requiring strict HTA submissions. DHA (Dubai) is more fragmented, with access gated by private insurance companies and TPA negotiations.

How important is Malaffi for market access?

Extremely. Malaffi provides the epidemiological baseline data needed to validate market sizing and budget impact models during P&T committee negotiations in Abu Dhabi.

Abu Dhabi DOH vs. Dubai DHA: The 2026 Formulary Submission Guide for the UAE

The UAE is the second-largest pharmaceutical market in the GCC, characterized by rapid adoption of innovative therapies and a sophisticated regulatory environment. However, access is deeply bifurcated between the two major emirates.

1. The Core Infrastructure

Before submission, commercial teams must understand the foundational architecture of both emirates.

Abu Dhabi: Department of Health (DOH)

Highly structured and consolidated. The public network is SEHA (PureHealth), and Malaffi serves as the unified health information exchange.

Dubai: Dubai Health Authority (DHA)

Fragmented and overwhelmingly private-sector driven. Governed by DHA and MOHAP, with the ISAHD insurance framework mandating coverage for all residents.

2. Formulary Submission & Evaluation Criteria

The strategic approach differs fundamentally based on the target emirate.

Winning in Abu Dhabi (DOH & SEHA)

Health Technology Assessment (HTA): Rigorous pharmacoeconomic modeling is mandatory. Localization of data to show Abu Dhabi-specific cost-offsets is critical.
Localization Advantage: Price preference and expedited registration for companies localizing manufacturing.

Winning in Dubai (DHA & Private Payers)

Fragmented Payer Negotiations: Securing reimbursement requires negotiating with dozens of private insurers and TPAs.
Physician Pull-Through: In Dubai, top specialists at private hospitals drive market access by pushing TPAs for coverage of innovative therapies.

3. The Price-Referencing Challenge

Both emirates use International Reference Pricing (IRP). A high-priced entry in Dubai that fails Abu Dhabi's strict HTA thresholds can lead to a national price cut that ripples across the entire GCC.

4. Key Takeaways for 2026 Brand Planning

1. Divide commercial operations distinctly between DOH and DHA. 2. Prioritize HEOR evidence for Abu Dhabi. 3. Prioritize KOL and brand-awareness for Dubai's private sector.

Abu Dhabi DOH vs. Dubai DHA: The 2026 Formulary Submissio...

Executive Summary